期刊文献+

wortmannin对高糖视网膜Müller细胞条件培养基诱导的内皮细胞增殖和迁移的影响 被引量:2

Effect of wortmannin on endothelial cell proliferation and migration induced by high glucose Müller cell conditioned medium
原文传递
导出
摘要 目的 探讨wortmannin抗眼内新生血管形成的可能。方法 采用免疫荧光、流式细胞分析和Boyden小室迁移实验观察高糖视网膜Müller细胞条件培养基(HGMCM)诱导的内皮细胞增殖和迁移的影响。结果 50nmol/Lwortmannin可明显抑制HGMCM诱导的内皮细胞的增殖和迁移,使内皮细胞S期细胞百分率明显下降[ (37 .82±0 .57)%至(21. 91±0 .23)%,P<0 .01],G0 /G1 期细胞百分率显著升高[ (54 .57±1 .19)%至(65. 59±0. 41)%,P<0 .01],G2 /M期细胞增多(P<0 .05)。结论 wortmannin对HGMCM诱导的内皮细胞的增殖和迁移均有抑制作用,提示wortmannin具有抗视网膜新生血管形成的作用。 Objective To investigate the effect of wortmannin on endothelial cells prolifer ation and migration induced by high glucose Müller cell conditioned medium (HGM CM). Methods Immunofluorescence, flow cytometry and Boyden chamber migration model s were used to analyze the effect of wortmannin on endothelial cells. Results 50 nmol/L wortmannin could significantly inhibit the proliferation an d migration of endothelial cells induced by HGMCM. The percentage of endothelial cells in S phase was obviously decreased [from (37.82±0.57)% to (21.91±0 .23)%, P< 0.01], while there was an increase in the percentage of cells in G 0/G 1 phase [from (54.57±1.19)% to (65.59±0.41)%, P<0.01] and G 2/M phase (P<0.05). Conclusion Wortmannin can inhibit proliferation and migration of endothelial cel ls induced by HGMCM, suggesting that wortmannin carries an anti-angiogenetic ab ility in diseased retina.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2005年第4期229-232,共4页 Chinese Journal of Pathology
基金 吉林省科学基金资助项目(990575 5)
关键词 WORTMANNIN 高糖视网膜 MÜLLER细胞 培养基 诱导作用 内皮细胞增殖 细胞迁移 1-磷脂酰肌醇3-激酶 Diabetic retinopathy Cell, cultured 1-phosphatidylinositol 3-ki nase
  • 相关文献

参考文献11

  • 1王越晖,宋鄂,冷瀛,吴家祥.兔视网膜Müller细胞原代培养[J].吉林大学学报(医学版),2003,29(3):367-369. 被引量:12
  • 2Forrseter JV, Shafiee A, Schroder S, et al. The role of growth factors in proliferative diabetic retinopathy.Eye, 1993,7:276-287.
  • 3Mizutani M, Gerhardinger C, Lorenzi M. Müller cell changes in human diabetic retinopathy.Diabetes, 1998, 47:445-449.
  • 4Puro DG. Growth factor and Muller cell.Prog Rtinal and Eye Res, 1995, 15:89-101.
  • 5Kroll J, Waltenberger J.The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells.J Biol Chem,1997,272: 32521-32527.
  • 6Derman MP, Toker A, Hartwig JH,et al.The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C.J Biol Chem,1997,272:6465 - 6470.
  • 7Begum N, Ragolia L, Rienzie J,et al. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells.Evaluation of the role of thenitric oxide signaling pathway and potential defects in hypertension.J Biol Chem,1998, 273:25164-25170.
  • 8Thakker GD, Hajjar DP, Muller WA, et al. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling.J Biol Chem, 1999,274:10002-10007.
  • 9Prosperi E.Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control.Prog Cell Cycle Res,1997,3:193-210.
  • 10Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ion, 2003,107:1322-1328.

二级参考文献6

  • 1Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment [J]. Proctor lecture. Invest Ophthalmol Vis Sci, 1988. 29 (12): 1771-1783.
  • 2Nork TM, Wallow IH, Sramek SJ, et al. Miiller's cell involvement in proliferative diabetic retinopathy [J]. Arch Ophthalmol, 1987. 105 (10): 1424-1429.
  • 3Wakakura M, Foulds WS. Immunocytochemical characteristics of Muller cells cultured from adult rabbit retina [J], Invest Ophthalmol Vis Sci, 1988, 29 (6); 892-900.
  • 4Vinores SA,Campochiaro PA,Conway BP.et al. Ultrastructral and electronimmunocytochemical characterization of cells in epiretinal membranes [J]. Invest Ophthalmol Vis Sci. 1990.31(1): 14-28.
  • 5Capetandes A, Gerritsen ME. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes [J], Invest Ophthalmol Vis Sci, 1990,31 (9) : 1738-1744.
  • 6杨雄里.Müler细胞与视网膜功能[J].生理科学进展,1998,29(1):7-10. 被引量:6

共引文献11

同被引文献16

  • 1王应利,惠延年,郭斌,张晓光,侯旭,马吉献.共培养系统中视网膜微血管周细胞经KDR/Flk-1途径对内皮细胞增生的影响(英文)[J].国际眼科杂志,2006,6(2):255-263. 被引量:5
  • 2邓爱军,姜德咏.缺氧时视网膜血管内皮细胞HIF-1 α及其mRNA的表达[J].眼科研究,2006,24(4):356-358. 被引量:7
  • 3黄敏丽,陈维平,何少健,陈芳,罗国容.大鼠视网膜Müller细胞的培养与鉴定[J].广西医科大学学报,2007,24(2):223-224. 被引量:7
  • 4Hampton T. Scientists take aim at angiogenesis to treat degenerative eye diseases [ J ]. JAMA,2004,291 ( 11 ) : 1309 - 1310
  • 5Maeshima Y, Sudhakar A, Lively JC, et al. Tumstatin, an endothelial cell- specific inhibitor of protein synthesis [ J ]. Science, 2002,295 ( 5552 ) : 140 - 143
  • 6Ciardella AP, Donsoff IM, Guyer DR, et al. Antiangiogenesis agents [ J ]. Ophthalmol Clin North Am ,2002,15 (4) : 453 - 458
  • 7Lang Z, Guerrera M, Li R, et al. Ganglioside GDIa enhances VEGF- induced endothelial cell proliferation and migration [ J ]. Biochem Biophys Res Commun,2001,282(4): 1031 - 1037
  • 8Bikfalvi A. Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system [ J ]. Biochem Pharmacol ,2004,68 (6) : 1017 - 1021
  • 9OReilly M, Boehm S, Shing T, et al. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth [ J ]. Cell, 1997,88 ( 2 ) : 277 - 285
  • 10Hamano Y,Kalluri R. Tumstatin,the NCI domain of a3 chain of type Ⅳ collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth [ J ]. Biochem Biophys Res Commun, 2005,333 (2): 292 - 298

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部